Viva Biotech Holdings (VB0) — Cash Flow Quality Index
Viva Biotech Holdings (VB0) has a Cash Flow Quality Index of 313.38x as of June 2023. Operating cash flow of €158.72 Million exceeds net income of €506.50K, indicating high earnings quality where cash backs reported profits. Explore VB0 cash flow conversion to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Viva Biotech Holdings Cash Flow Quality Index (2016–2024)
Historical Cash Flow Quality Index for Viva Biotech Holdings across 6 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check VB0 capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Viva Biotech Holdings (2016–2024)
Year-by-year earnings quality comparison for Viva Biotech Holdings. For live market cap and the full company financial profile, see market value of Viva Biotech Holdings.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 2.24x | €373.99 Million | €167.29 Million | ▲ +725.9% |
| 2021 | 0.27x | €77.83 Million | €287.55 Million | ▲ +56.4% |
| 2019 | 0.17x | €46.01 Million | €265.90 Million | ▲ +29.4% |
| 2018 | 0.13x | €12.11 Million | €90.55 Million | ▼ -63.4% |
| 2017 | 0.37x | €27.89 Million | €76.26 Million | ▼ -57.6% |
| 2016 | 0.86x | €21.12 Million | €24.47 Million | — |